Inovio Pharmaceuticals Inc (INO)

[mackwheaton]

If they could, they would buy back shares. But INO is a Wild West stock. Analysts like tangible assets, revenues, margins, earnings as their compass. For INO and most early stage biotechs, there is none of this except an attempt to value the assets. You can see how that is working.

Institutional investors are notoriously patient, except when a stock hits a threshold. For INO, when it breached a dollar, it opened up to a whole new set of investors, big investors. They bought up big chunks and drove the stock to $3. Many bought in the $1s then told their clients to buy. Most of the buying above $2 was probably retail. Retail investors get discouraged quickly and sell. Instis hold and buy up the cheaper shares without having to chase.

We have had a partnership, conferences and numerous positive articles this week and the stock has gone down. It will not move up without news. It will drift down without it.

It is not manipulation.

The vacuum created by an absence of evidence is filled by reasonable doubt. If you believe in the stock, buy at the lower prices when you feel comfortable. I love the company's potential but I currently hate the price action. I'm out until it figures out a base. In 5 years today's prices will not matter, but if I can buy at 1.80 what I sold at 2.40 I can add 40% more shares to my holdings. And in 5 years that may matter lot. Good luck, I remain very optimistic about the prospects, Kim's epic comment I probably right on target.